Common variable immunodeficiency at the end of a prospering decade: Towards novel gene defects and beyond

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 6, 2010, Pages 526-533

  Eibel, Hermann ^a   Salzer, Ulrich ^a   Warnatz, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

B cells; BAFF R; CD21; common variable immunodeficiency; primary immunodeficiency

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; CD20 ANTIGEN; CD81 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR;

B LYMPHOCYTE; CALCIUM SIGNALING; CELLULAR IMMUNITY; COHORT ANALYSIS; COMMON VARIABLE IMMUNODEFICIENCY; CONSANGUINEOUS MARRIAGE; GENETIC ASSOCIATION; HUMAN; IMMUNOGENETICS; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD20; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; CONSANGUINITY; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MUTATION; T-LYMPHOCYTES, REGULATORY;

EID: 78449256680     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833fea1c     Document Type: Review

References (62)

1. Wehr C, Kivioja T, Schmitt C, et al.The EUROclasstrial:defining subgroupsin common variable immunodeficiency. Blood 2008; 111:77-85.
2. Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009; 9:491-502.
3. Treml JF, Hao Y, Stadanlick JE, Cancro MP. The BLyS family: toward a molecular understanding of B cell homeostasis. Cell Biochem Biophys 2009; 53:1-16.
4. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997; 90:1073-1083.
5. Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004; 117:787-800.
6. Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000; 192:1453-1466.
7. Thompson JS, Schneider P, Kalled SL, et al. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral Bcell population.J Exp Med 2000; 192:129-135.
8. Yan M, Brady JR, Chan B, et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 2001; 11:1547-1552.
9. Sasaki Y, Casola S, Kutok JL, et al. TNF family memberB cell-activating factor (BAFF) receptor-dependent and-independent roles for BAFF in B cell physiology. J Immunol 2004; 173:2245-2252.
10. Rauch M, Tussiwand R, Bosco N, Rolink AG. Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One 2009; 4:e5456.
11. Claudio E, Brown K, Park S, et al. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 2002; 3:958-965.
12. Vallabhapurapu S, Matsuzawa A, Zhang W, et al. Nonredundant and com-plementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 2008; 9:1364-1370.
13. Sasaki Y, Calado DP, Derudder E, et al. NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells. Proc Natl Acad Sci USA 2008; 105:10883-10888.
14. Gardam S, Sierro F, Basten A, et al. TRAF2 and TRAF3 signal adapters act cooperativelytocontrol thematuration and survival signalsdelivered to Bcells by the BAFF receptor. Immunity 2008; 28:391-401.
15. Hsu BL, Harless SM, Lindsley RC, et al. Cutting edge: BLyS enables survival of transitional and mature Bcellsthrough distinct mediators. J Immunol 2002; 168:5993-5996.
16. Woodland RT, Fox CJ, Schmidt MR, et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008; 111:750-760.
17. Patke A, Mecklenbrauker I, Erdjument-Bromage H, et al. BAFF controls B cell metabolic fitness through a PKC beta-and Akt-dependent mechanism. J Exp Med 2006; 203:2551-2562.
18. Otipoby KL, Sasaki Y, Schmidt-Supprian M, et al. BAFFactivates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci USA 2008; 105:12435-12438.
19. Srinivasan L, Sasaki Y, Calado DP, et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell 2009; 139:573-586.
20. Stadanlick JE, Kaileh M, Karnell FG, et al.Tonic Bcell antigen receptorsignals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol 2008; 9:1379-1387.
21. Mohammadi J, Liu C, Aghamohammadi A, et al. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol 2009; 29:777-785.
22. Salzer U, Birmelin J, Bacchelli C, et al. Sequence analysis of TNFRSF13b, encoding TACI, in patientswith systemic lupuserythematosus. JClin Immunol 2007; 27:372-377.
23. Salzer U, Chapel HM, Webster AD, et al. Mutations inTNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005; 37:820-828.
24. Garibyan L, Lobito AA, Siegel RM, et al. Dominant-negative effect of the heterozygous C104RTACI mutation in common variable immunodeficiency (CVID). J Clin Invest 2007; 117:1550-1557.
25. Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005; 37:829-834.
26. Losi CG, Silini A, Fiorini C, et al. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 2005; 25:496-502.
27. Warnatz K, Salzer U, Rizzi M, et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA 2009; 106:13945-13950.
28. O'Connor BP, Raman VS, Erickson LD, et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 2004; 199:91-98.
29. 2+ conductance found constitutively in B lymphocytes. J Cell Biol 1993; 121:1121-1132.
30. Kanzaki M, Lindorfer MA, Garrison JC, Kojima I. Activation of the calcium-permeable cation channel CD20 by alpha subunits of the Gi protein. J Biol Chem 1997; 272:14733-14739.
31. Uchida J, Lee Y, Hasegawa M, et al. MouseCD20 expression andfunction. Int Immunol 2004; 16:119-129.
32. Kuijpers TW, Bende RJ, Baars PA, et al. CD20deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2010; 120: 214-222.
33. Van Zelm MC, Reisli I, van der Burg M, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006; 354: 1901-1912.
34. Van Zelm MC, Smet J, Adams B, et al. CD81 gene defect in humans disrupts CD19 complexformation and leadstoantibodydeficiency. J Clin Invest 2010; 120:1265-1274.
35. Tsitsikov EN, Gutierrez-Ramos JC, Geha RS. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc Natl Acad Sci USA 1997; 94:10844-10849.
36. Maecker HT, Levy S. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med 1997; 185:1505-1510.
37. Miyazaki T, Muller U, Campbell KS. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J 1997; 16:4217-4225.
38. Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007; 178:3932-3943.
39. Mouillot G, Carmagnat M, Gerard L, et al. B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol 2010; DOI 10.1007/s10875-010-9424-3.
40. Huck K, Feyen O, Ghosh S, et al. Memory B-cells in healthy and antibody-deficientchildren. Clin Immunol 2009; 131:50-59.
41. Van de Ven AA, van de Corput L, van Tilburg CM, et al. Lymphocyte characteristics in children with common variable immunodeficiency. Clin Immunol 2010; 135:63-71.
42. Yong PL, Orange JS, Sullivan KE. Pediatric common variable immunodefi-ciency: Immunologic and phenotypic associations with switched memory B cells. Pediatr Allergy Immunol 2010; 21:852-858.
43. Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112: 277-286.
44. Kalina T, Stuchly J, Janda A, et al. Profiling of polychromatic flow cytometry data on B-cells reveals patients' clusters in common variable immunodefi-ciency. Cytometry A 2009; 75:902-909.
45. Cunningham-Rundles C, Radigan L, Knight AK, et al. TLR9 activation is defective in common variable immune deficiency. J Immunol 2006; 176:1978-1987. (Pubitemid 43134344)
46. Yu JE, Knight AK, Radigan L, et al. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol 2009; 124:349-356.
47. Escobar D, Pons J, Clemente A, et al. Defective B cell response to TLR9 ligand (CpG-ODN), Streptococcuspneumoniaeand Haemophilusinfluenzae extracts in common variable immunodeficiency patients. Cell Immunol 2010; 262:105-111.
48. Moir S, Fauci AS. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 2008; 122:12-19.
49. low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci USA 2009; 106:13451-13456.
50. Moir S, Ho J, Malaspina A, et al. Evidencefor HIV-associated Bcell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 2008; 205:1797-1805.
51. Isnardi I, Ng YS, Menard L, et al. Complement receptor 2/CD21-negative human naive B cells mostly contain autoreactive unresponsive clones. Blood 2010; 115:5026-5036.
52. Ehrhardt GR, Hijikata A, Kitamura H, et al. Discriminating gene expression profilesof memory Bcell subpopulations. J Exp Med 2008; 205:1807-1817.
53. Foerster C, Voelxen N, Rakhmanov M, et al. B cell receptor-mediated calcium signaling is impaired in B lymphocytes of type Ia patients with common variable immunodeficiency. J Immunol 2010; 184:7305-7313.
54. Borte S, Pan-Hammarstrom Q, Liu C, et al. Interleukin-21 restores immuno-globulin production ex vivo in patients with common variable immunodefi-ciency and selective IgA deficiency. Blood 2009; 114:4089-4098.
55. Horn J, Manguiat A, Berglund LJ, et al. Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 2009; 156:446-454.
56. low B lymphocytes. J Clin Immunol 2010; 30:292-300.
57. Genre J, Errante PR, Kokron CM, et al. Reduced frequency of CD4(+)CD25(HIGH)FOXP3(+) cells and diminished FOXP3 expression in patients with Common Variable Immunodeficiency: a linkto autoimmunity? Clin Immunol 2009; 132:215-221.
58. Melo KM, Carvalho KI, Bruno FR, et al. Adecreased frequency of regulatoryT cells in patients with common variable immunodeficiency. PLoS One 2009; 4:e6269.
59. Yu GP,Chiang D,Song SJ, et al. Regulatory T cell dysfunction in subjectswith common variable immunodeficiency complicated by autoimmune disease. Clin Immunol 2009; 131:240-253.
60. Fulcher DA, Avery DT, Fewings NL, et al. Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency. Clin Exp Immunol 2009; 157:365-369.
61. Rezaei N, Wing JB, Aghamohammadi A, et al. B-cell-T-cell activation and interaction in common variable immunodeficiency. Hum Immunol 2010; 71:355-362.
62. Malphettes M, Gerard L, Carmagnat M, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009; 49:1329-1338.